SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042612
Filing Date
2019-11-12
Accepted
2019-11-12 08:20:51
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrr-10q_20190930.htm   iXBRL 10-Q 3269780
2 EX-31.1 tcrr-ex311_40.htm EX-31.1 10687
3 EX-31.2 tcrr-ex312_39.htm EX-31.2 10741
4 EX-32.1 tcrr-ex321_38.htm EX-32.1 9564
5 GRAPHIC gsvj04qhhcke000001.jpg GRAPHIC 2978
  Complete submission text file 0001564590-19-042612.txt   8960367

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20190930.xsd EX-101.SCH 42444
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcrr-20190930_cal.xml EX-101.CAL 44482
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcrr-20190930_def.xml EX-101.DEF 154330
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20190930_lab.xml EX-101.LAB 380064
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20190930_pre.xml EX-101.PRE 287217
47 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-10q_20190930_htm.xml XML 1595668
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38811 | Film No.: 191206326
SIC: 2836 Biological Products, (No Diagnostic Substances)